Cargando…
Muscle fibrosis as a prognostic biomarker in facioscapulohumeral muscular dystrophy: a retrospective cohort study
Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant epigenetic disorder with highly variable muscle involvement and disease progression. Ongoing clinical trials, aimed at counteracting muscle degeneration and disease progression in FSHD patients, increase the need for reliable bio...
Autores principales: | Ragozzino, Elvira, Bortolani, Sara, Di Pietro, Lorena, Papait, Andrea, Parolini, Ornella, Monforte, Mauro, Tasca, Giorgio, Ricci, Enzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583430/ https://www.ncbi.nlm.nih.gov/pubmed/37849014 http://dx.doi.org/10.1186/s40478-023-01660-4 |
Ejemplares similares
-
Non-myogenic mesenchymal cells contribute to muscle degeneration in facioscapulohumeral muscular dystrophy patients
por: Di Pietro, Lorena, et al.
Publicado: (2022) -
Proteomics of Muscle Microdialysates Identifies Potential Circulating Biomarkers in Facioscapulohumeral Muscular Dystrophy
por: Corasolla Carregari, Victor, et al.
Publicado: (2020) -
Tracking muscle wasting and disease activity in facioscapulohumeral muscular dystrophy by qualitative longitudinal imaging
por: Monforte, Mauro, et al.
Publicado: (2019) -
Upper Girdle Imaging in Facioscapulohumeral Muscular Dystrophy
por: Tasca, Giorgio, et al.
Publicado: (2014) -
Redox Homeostasis in Muscular Dystrophies
por: Mosca, Nicola, et al.
Publicado: (2021)